Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Gasche

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Molecular Interventions|August 27, 2005
Chemoprevention goes gourmet: different flavors of NO-aspirinAjay Goel, Christoph Gasche, C Richard Boland
Gastroenterology & Hepatology|April 22, 2016
Management of Iron Deficiency AnemiaKristine Jimenez, Stefanie Kulnigg-Dabsch, Christoph Gasche
European Journal of Gastroenterology & Hepatology|July 4, 2003
Genotype-phenotype correlations: how many disorders constitute inflammatory bowel disease?Christoph Gasche, Behrooz Z Alizadeh, A Salvador Peña
European Journal of Gastroenterology & Hepatology|February 18, 2005
Anatomy of the GI tract in US: an historical perspectiveWolfgang Miehsler, Andreas Püspök, Karl Turetschek, et al.
Cancer Research|May 19, 2005
Mesalazine improves replication fidelity in cultured colorectal cellsChristoph Gasche, Ajay Goel, Loki Natarajan, et al.
Plos One|April 17, 2012
Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemiaStefanie Kulnigg-Dabsch, Rayko Evstatiev, Clemens Dejaco, et al.
International Journal of Inflammation|April 27, 2012
Inflammatory bowel diseaseDavid B Sachar, Derek Jewell, Christoph Gasche, et al.
The American Journal of Gastroenterology|June 4, 2009
Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatmentStefanie Kulnigg, Lena Teischinger, Clemens Dejaco, et al.
Geriatrics (Basel, Switzerland)|April 24, 2019
p-21 Activated Kinase as a Molecular Target for Chemoprevention in DiabetesKyle Dammann, Vineeta Khare, Clyde Coleman, et al.
International Journal of Oncology|February 28, 2012
Improvement of replication fidelity by certain mesalazine derivativesClemens Honeder, Christoph Campregher, Bettina Zens, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Molecular Interventions|August 27, 2005
Chemoprevention goes gourmet: different flavors of NO-aspirinAjay Goel, Christoph Gasche, C Richard Boland
Gastroenterology & Hepatology|April 22, 2016
Management of Iron Deficiency AnemiaKristine Jimenez, Stefanie Kulnigg-Dabsch, Christoph Gasche
European Journal of Gastroenterology & Hepatology|July 4, 2003
Genotype-phenotype correlations: how many disorders constitute inflammatory bowel disease?Christoph Gasche, Behrooz Z Alizadeh, A Salvador Peña
European Journal of Gastroenterology & Hepatology|February 18, 2005
Anatomy of the GI tract in US: an historical perspectiveWolfgang Miehsler, Andreas Püspök, Karl Turetschek, et al.
Cancer Research|May 19, 2005
Mesalazine improves replication fidelity in cultured colorectal cellsChristoph Gasche, Ajay Goel, Loki Natarajan, et al.
Plos One|April 17, 2012
Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemiaStefanie Kulnigg-Dabsch, Rayko Evstatiev, Clemens Dejaco, et al.
International Journal of Inflammation|April 27, 2012
Inflammatory bowel diseaseDavid B Sachar, Derek Jewell, Christoph Gasche, et al.
The American Journal of Gastroenterology|June 4, 2009
Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatmentStefanie Kulnigg, Lena Teischinger, Clemens Dejaco, et al.
Geriatrics (Basel, Switzerland)|April 24, 2019
p-21 Activated Kinase as a Molecular Target for Chemoprevention in DiabetesKyle Dammann, Vineeta Khare, Clyde Coleman, et al.
International Journal of Oncology|February 28, 2012
Improvement of replication fidelity by certain mesalazine derivativesClemens Honeder, Christoph Campregher, Bettina Zens, et al.
Pageof 11